ISEH 2021 Annual Meeting
“Human pluripotent stem cell-derived hematopoiesis”:
From development to stem cell therapies
*Postponed to 2021 due to COVID-19
New York Marriott at the Brooklyn Bridge Brooklyn, New York, NY
Organizers: George Q. Daley, Eirini Papapetrou, Sergei Doulatov
*Satellite symposium postponed until 2021!
Thank you all for your interest in the iPSC-hematopoiesis satellite meeting we had planned for this August in conjunction with the ISEH meeting.
Unfortunately, in view of the COVID-19 pandemic, we had to make the hard decision to postpone our meeting.
Our new meeting date is being scheduled for late August 2021, again in New York and again as a pre-meeting to the annual ISEH meeting, which will also take place in New York in 2021.
We will post new details once our plans are finalized.
We thank everyone for your support and enthusiastic responses to our first call and we remain committed to make this special meeting happen next year and the years after that!
Goals of the symposium
This symposium aims to bring together researchers working in the fields of blood development, hPSC modeling of blood diseases, and generation of hPSC-derived blood products for cell replacement therapies and immuno-therapies. Topics will include recent advances in characterizing the ontogeny of the hematopoietic system, in generating disease models of non-malignant and malignant blood diseases and in developing cell and gene therapies using hPSC-derived cells. Our goal is to build, expand and foster a community of researchers who share common interests in better methods to generate blood cells from pluripotent stem cell sources with an emphasis on human hematopoiesis from hPSCs. We are planning one full day of speaker sessions, educational session, and lively discussion and envision turning this into an annual event.
The satellite symposium will take place 1 day before the general ISEH meeting and cover these topics:
Basic studies of hPSC-derived hematopoiesis and hematopoietic stem cells.
iPSC models of blood diseases
Latest research to use iPSCs to model benign and malignant blood disorders.
hPSC-derived blood cells for therapy
Generation of clinically valuable blood cell types for cell therapy from hPSCs.
Discussion of methods and protocols for hPSC culture and differentiation